ROCKVILLE, Md., Feb. 23, 2016 /PRNewswire/ -- Therabron Therapeutics, Inc., a clinical-stage biotechnology company dedicated to advancing a new standard in respiratory care, today announced that its President and Chief Executive Officer, Dr. Thomas F. Miller, will give a corporate presentation at the BioCentury 23rd Annual Future Leaders in the Biotech Industry Conference. Additional information is as follows:
Date: | Friday, March 11, 2016 |
Time: | 2:40 pm ET |
Location: | Millennium Hotel |
145 West 44th Street | |
Room 508 | |
New York, NY |
About Therabron Therapeutics, Inc.
At Therabron Therapeutics, we are advancing a platform of novel therapeutic proteins in an effort to change how a variety of neglected and under-treated respiratory and fibrotic conditions are managed. We are a privately held, clinical-stage, biopharmaceutical company, developing a new class of drugs based on the naturally occurring secretoglobin family of proteins which includes the CC10 protein -- a molecule with both anti-inflammatory and immunomodulatory mechanisms. Therabron’s product candidates have the potential to become first-in-class, biologic therapeutics. For additional information, please visit www.therabron.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/therabron-therapeutics-to-present-at-biocentury-23rd-annual-future-leaders-in-the-biotech-industry-conference-300224348.html
SOURCE Therabron Therapeutics, Inc.
